The short answer
DSIP is supplied lyophilised and is most stable in that state, stored cold, dry and protected from light. It has neither cysteine nor methionine, so disulfide chemistry and methionine oxidation do not apply. Its strongly acidic character is the main variable affecting solubility.
Key facts
- Supplied as
- White lyophilised powder
- Disulfide risk
- None (no cysteine)
- Methionine oxidation
- Not applicable (none present)
- Main route
- Hydrolysis
- Charge
- Strongly negative at physiological pH
- Light
- Single tryptophan is mildly photosensitive
- Freeze-thaw
- Avoid by aliquoting
Why lyophilised is the stable state
Water participates in peptide-bond hydrolysis, so removing it removes the principal degradation route. A dry powder held cold has limited chemistry available to it. This applies to research peptides generally, and it is why the condition of material on arrival matters. A warm transit is time spent in a less protected state.
What does not apply here
Most peptide handling guidance addresses two liabilities. Cysteine forms and scrambles disulfide bonds; methionine oxidises to the sulfoxide, adding 16 Da. DSIP has neither residue. That removes the two most commonly discussed failure modes and makes it, chemically, one of the more forgiving research peptides.
Research material referenced
DSIP 5mg, third-party HPLC tested
The tryptophan is the reason to keep it dark
Tryptophan at position 1 is mildly photosensitive and can degrade under prolonged light exposure. This is a weaker liability than methionine oxidation but it is the one DSIP actually has, and it is a specific reason to protect solutions from light rather than a generic instruction.
Charge and solubility
With aspartate and glutamate and no basic residue, DSIP is strongly negatively charged at physiological pH. Solubility of a charged peptide is pH-dependent and drops near its isoelectric point, which for an acidic peptide sits low. Behaviour in bacteriostatic water at pH 5.7 may therefore differ noticeably from behaviour in a neutral buffer. Worth knowing if a preparation dissolves less readily than expected.
Reconstitution
Bacteriostatic water is the usual diluent for research peptides, its benzyl alcohol permitting repeated entry over a limited window. Introduce solvent gently against the vial wall rather than onto the powder, and swirl rather than shake. Peptides denature at air-liquid interfaces, and foaming is the visible sign that one has been created.
After reconstitution
Solution-phase material is subject to hydrolysis and is markedly less stable than the lyophilised powder. Aliquot into single-use volumes rather than freeze-thawing repeatedly; each cycle concentrates solutes at the advancing ice boundary and creates further interfaces. Cloudiness, particulates or discolouration mean the material should not be relied on for a measurement.
Frequently asked questions
Does DSIP need a reducing agent?
No. Reducing agents address disulfide chemistry, and there is no cysteine in the sequence.
Why protect DSIP from light if it has no methionine?
Its single tryptophan is mildly photosensitive. It is a weaker liability than methionine oxidation but it is the one this sequence has.
Why might DSIP dissolve unevenly?
It is strongly acidic with no basic residue, and solubility of a charged peptide is pH-dependent. The diluent's pH is a real variable.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubChemPubChem · Delta sleep-inducing peptide (CID 68816)pubchem.ncbi.nlm.nih.gov
- PubMedStability of protein pharmaceuticals: an update. Pharm Res (PMID 20143256)pubmed.ncbi.nlm.nih.gov
- PubMedNail SL et al., Fundamentals of freeze-drying. Pharm Biotechnol 2002 (PMID 12189727)pubmed.ncbi.nlm.nih.gov
Browse the wider literature
Live database searches, not fixed citations. Results change as new work is indexed.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More DSIP (Delta Sleep-Inducing Peptide) articles
- DSIP in the Published LiteratureAbout 519 indexed PubMed records across nearly fifty years, and a central claim still unresolved. Why volume of publication is not weight of evidence.
- DSIP Regulatory StatusDSIP holds no marketing authorisation anywhere. It has an INN, emideltide, which is a naming decision rather than an approval - a distinction worth knowing.
- An Antibody Reports What It Binds, Not What Is ThereRIA generated most of the DSIP distribution literature. It measures immunoreactivity - which is a statement about an antibody, not about a molecule.
- What the Antibody Found in Peripheral TissueGraf and Kastin measured DSIP-like material across 12 rat tissues - highest in stomach - then showed chromatography put most of it at a larger size.
- What Adrenalectomy ChangedBjartell 1991 measured immunoreactive DSIP in rat hypothalamus, pituitary and adrenal gland, and examined what removing the adrenals did to it.